Schizophrenia Trial, Recruiting (NCT07395206)

Schizophrenia Trial, Recruiting NCT07395206 Sponsor: Charite University, Berlin, Germany Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07395206 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Schizophrenia or Schizoaffective Disorder (these are specific mental health conditions)
You are between 18 and 65 years old
You can speak and understand German well enough to participate
You are able to use a smartphone

Who may not be able to join:

You are currently attending more than one psychotherapy session per month
Your current overall illness severity falls outside a certain range, meaning your symptoms are either too mild or too severe (confirm with trial site)
You do not own or have access to a smartphone
You have a neurological condition or have experienced brain damage
You are currently having thoughts of suicide or are considered at acute risk
You are currently struggling with serious substance misuse or addiction
You are currently receiving electroconvulsive therapy (a treatment that uses electrical stimulation to the brain)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049 30 450 617 325

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07395206

Sponsor: Charite University, Berlin, Germany

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 0049 30 450 617 325

More information: https://clinicaltrials.gov/study/NCT07395206

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Schizophrenia or Schizoaffective Disorder (these are specific mental health conditions)
You are between 18 and 65 years old
You can speak and understand German well enough to participate
You are able to use a smartphone

Who may not be able to join:

You are currently attending more than one psychotherapy session per month
Your current overall illness severity falls outside a certain range, meaning your symptoms are either too mild or too severe (confirm with trial site)
You do not own or have access to a smartphone
You have a neurological condition or have experienced brain damage
You are currently having thoughts of suicide or are considered at acute risk
You are currently struggling with serious substance misuse or addiction
You are currently receiving electroconvulsive therapy (a treatment that uses electrical stimulation to the brain)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

30 January 2026

Est. completion

30 June 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Proportion of PP receiving threshold dose (Acceptability); Nr. of pp willing to participate (Feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov